Straits Research

Global Neurological Biomarkers Market: A Comprehensive Analysis Market Overview The global neurological biomarkers market has witnessed significant growth in recent years, with a valuation of USD 7,823.39 million in 2022. Projections indicate that the market will expand to USD 23,332.71 million by 2031, growing at a compound annual growth rate (CAGR) of 12.91% during the forecast period from 2023 to 2031. This growth is primarily driven by the increasing prevalence of neurological disorders and the rising investment in research and development (R&D) for biomarkers. Neurological biomarkers, which are molecules found in blood or cerebral spinal fluid (CSF), play a crucial role in diagnosing neurological conditions and monitoring disease progression. Advances in detection technologies and the development of biomarker signatures have made neurological diseases more manageable, further fueling market demand. Neurological biomarkers are essential in clinical practice, particularly in dru...